In patients with chronic lymphocytic leukaemia, Bcl2 also encourages cell exhaustion and inhibits CD8 + T cell killing activity via the increase in Treg abundance [32]. This evidence concerns the gene BCL2 and B-cell chronic lymphocytic leukemia.